Share your story and shine at JK Monitor!🌟 Welcome to JK Monitor, where every story matters and every achievement is celebrated! We invite you to share the remarkable journey of your life and showcase your accomplishments to the world. Join our exclusive interviews that honor exceptional individuals just like you. For most of human history, a silent, invisible defense has stood between us and the vast, spore-filled world around us: our own body heat. At a core temperature of roughly 37°C (98.6°F), the human body has functioned as a formidable thermal fortress, a biological barrier that keeps the vast majority of the planet’s estimated 3 to 5 million fungal species from gaining a foothold inside us. Only a tiny fraction—roughly 300 to 400 species—are currently capable of infecting humans, and most of these are opportunistic pathogens that primarily threaten those with weakened immune systems.
That fortress, however, is showing signs of strain from two opposing directions. On one side, a warming climate is applying selective pressure on environmental fungi to adapt to higher temperatures. On the other, the average human body temperature itself is quietly declining. The convergence of these trends has alarmed infectious disease experts, who warn that the thermal shield protecting mammals from fungal disease could become less effective—with potentially grave consequences for the most vulnerable among us: hospital patients.
A Harbinger in the Hospital Halls
The most concerning example of this shifting balance is Candida auris, a yeast first identified in Japan in 2009. Unlike its closest relatives, which grow poorly at mammalian temperatures, C. auris thrives at 37°C, tolerates temperatures as high as 47°C, persists on hospital surfaces for weeks, and resists all three major classes of antifungal drugs. It is, in the words of a 2026 review published in mSphere, “a harbinger of novel fungal pathogens”.
The pathogen’s rise has been swift and unsettling. Within a decade of its identification, genetically distinct, multidrug-resistant clades of C. auris emerged independently on five continents—a pattern that points to shared selective pressures rather than clonal spread. In the United States, the Centers for Disease Control and Prevention (CDC) recorded 7,045 clinical cases of C. auris as of December 20, 2025—a 56.1% increase from the 4,514 cases logged in 2023. Nevada and California alone accounted for roughly half of those cases, with Nevada reporting 1,605 infections and California 1,524.
The clinical picture is stark. C. auris can colonize patients for months without symptoms, but 5 to 10% of colonized individuals develop a bloodstream infection, and mortality from invasive candidiasis ranges from 30% to 60%. Without treatment, mortality can reach 45% within 30 days. The fungus spreads easily in healthcare settings—particularly long-term acute care hospitals and ventilator-capable skilled nursing facilities—aided by its ability to survive on surfaces and medical equipment and its resistance to common disinfectants.
The Cooling Host
While fungi are adapting to heat, humans are, in a sense, becoming less hot. A landmark 2020 study led by researchers at Stanford University analyzed temperature records from three cohorts spanning 157 years—including Union Army veterans from the Civil War era, participants in a 1970s national health survey, and patients in a modern Stanford database—totaling more than 189,000 individual measurements. After adjusting for age, height, weight, and other factors, the researchers found that mean body temperature in men and women has decreased monotonically by 0.03°C per birth decade.
“Our temperature’s not what people think it is,” said Dr. Julie Parsonnet, professor of medicine and of health research and policy at Stanford and a senior author of the study. The findings suggest that the canonical 37°C standard established in the 19th century no longer reflects the modern average, which is closer to 36.6°C. The researchers hypothesized that the decline reflects a reduction in metabolic rate, likely driven by lower levels of chronic inflammation as a result of improved hygiene, reduced exposure to pathogens, and better living conditions.
The implications for fungal defense are subtle but potentially significant. A cooler body temperature means a narrower thermal margin between the environment in which fungi thrive and the environment inside a human host. “The convergence of warming environments and cooling hosts accelerates the collapse of the millennia-old thermal shield of mammals,” wrote the authors of the mSphere review. They noted that with a current gap between global mean temperature and average human body temperature of approximately 22°C, every 1°C rise in global mean temperature reduces the protective thermal gradient by about 5%.
A Perfect Storm in Healthcare
Scientists have not established a direct causal link between declining human body temperature and the rise of C. auris or other thermotolerant fungi. The Stanford researchers who documented the temperature decline were studying metabolic and inflammatory trends, not fungal pathogenesis. And some mycologists have cautioned against overstating the thermal barrier’s importance, noting that growth at 37°C is not the sole determinant of fungal pathogenicity and that tens of thousands of nonpathogenic fungi can also grow at mammalian temperatures.
Yet the convergence of trends is difficult to ignore. Climate change is widely recognized as a driver of fungal adaptation. A 2026 systematic review in the Brazilian Journal of Infectious Diseases identified thermal adaptation and heat tolerance in pathogenic fungi—particularly C. auris and Aspergillus fumigatus—as the most prominent theme in the climate-fungal disease literature, accounting for 30% of analyzed studies. A separate 2025 review in Thorax noted that rising temperatures and extreme weather events are “thought to be driving the adaptation of fungal pathogens to new climates,” expanding their range and posing a growing threat to human health.
Laboratory evidence supports the concern. A 2020 study found that most C. auris isolates displayed significant growth at 47°C and were relatively resistant to combinatorial stress—for example, surviving at pH 13 combined with 47°C heat. A 2025 proof-of-principle study from Johns Hopkins University collected fungi from sidewalks across Baltimore and found that species from warmer urban sites had greater heat resistance in the laboratory than the same species from cooler sites, suggesting that fungi may be adapting to higher temperatures within cities.
“This study opens the door for future research into these adaptations and the identification of urban fungal species that may emerge as potential human pathogens in the near future,” said Daniel Smith, the study’s first author.
Dr. Arturo Casadevall, a Bloomberg Distinguished Professor at Johns Hopkins and author of the book Will the Fungi Win?, has argued that C. auris may have acquired its thermotolerance only recently, due in part to global warming. He has described the human thermal barrier as “our normal body temperature, and it has been holding the majority of fungal infections in humans at bay”.
Why Hospital Patients Bear the Brunt
If the thermal barrier erodes, the first and most severe consequences will likely be felt in hospitals—not among the general public. Fungal infections are already a significant burden: at least 6.5 million people suffer from invasive fungal infections each year, with 2.5 million deaths directly attributable, according to estimates cited in the mSphere review. Those figures are almost certainly underestimates given uneven global surveillance and diagnostics.
Hospitalized patients are uniquely vulnerable. Indwelling devices such as ventilators, central lines, and catheters provide direct routes for fungal entry. Prolonged stays in intensive care units and long-term care facilities increase exposure to environmental spores and colonized surfaces. Immunosuppression—whether from illness, medication, or age—blunts the adaptive immune system that serves as the second pillar of antifungal defense. C. auris exploits all of these vulnerabilities, spreading rapidly among patients who are already critically ill.
The prospect of more thermotolerant fungi entering the healthcare environment raises the stakes further. “If climate change enables even a small fraction of environmental fungi to breach the thermal barrier, the implications are profound,” the mSphere authors wrote, noting that mammals inhale 1 to 10 fungal spores with every breath and that fungi constitute the majority of airborne biomass. Exposure, in other words, is unavoidable.
A Call for Surveillance, Not Panic
Experts caution that this is not a scenario for science-fiction-style alarm. Fungi are unlikely to transform into a zombie-apocalypse threat, and the vast majority of species remain harmless to humans. But the trends merit attention. The World Health Organization has identified C. auris as a critical priority pathogen, and the CDC has emphasized the need for improved detection, infection control, and antifungal stewardship in healthcare settings.
The mSphere review calls for “predictive frameworks for fungal disease emergence” as an urgent priority, arguing that C. auris “may be the first of many fungi adapting to breach mammalian thermal defenses”. The Stanford body-temperature researchers, meanwhile, have framed their findings as a window into long-term changes in human physiology and health—changes that may have unanticipated consequences for host-pathogen interactions.
The thermal shield that has protected mammals for millions of years is not collapsing overnight. But it is thinning, from both sides. In a world where the environment is getting warmer and human bodies are getting cooler, the space between us and the fungal kingdom is narrowing. For hospital patients—the frail, the immunocompromised, the device-dependent—that narrowing could prove to be the difference between a fortress and a fragile line of defense.
